Skip to main content
. 2022 Nov 17;149(1):34–41. doi: 10.1001/jamaoto.2022.3636

Table. Distribution of Larynx Cancer Cases by Sex and Stage From 1986 to 2018a.

Year Cases, No. (%) Total cases, No.
Sex Stage
Male Female Localized Regional Distant Unknown or unspecified
1986 855 (82.1) 187 (17.9) 557 (53.5) 357 (34.3) 56 (5.4) 72 (6.9) 1042
1987 868 (79.4) 225 (20.6) 532 (48.7) 425 (38.9) 62 (5.7) 74 (6.8) 1093
1988 889 (80.7) 213 (19.3) 586 (53.2) 387 (35.1) 59 (5.4) 70 (6.4) 1102
1989 842 (78.3) 233 (21.7) 579 (53.9) 361 (33.6) 72 (6.7) 63 (5.9) 1075
1990 880 (79.6) 226 (20.4) 589 (53.3) 378 (34.2) 76 (6.9) 63 (5.7) 1106
1991 824 (79.2) 216 (20.8) 557 (53.6) 346 (33.3) 66 (6.3) 71 (6.8) 1040
1992 1196 (81.3) 275 (18.7) 774 (52.6) 489 (33.2) 105 (7.1) 103 (7.0) 1471
1993 1090 (81.6) 245 (18.4) 717 (53.7) 449 (33.6) 79 (5.9) 90 (6.7) 1335
1994 1121 (78.3) 311 (21.7) 765 (53.4) 501 (35.0) 88 (6.1) 78 (5.4) 1432
1995 1130 (80.3) 278 (19.7) 779 (55.3) 457 (32.5) 104 (7.4) 68 (4.8) 1408
1996 1075 (78.5) 295 (21.5) 742 (54.2) 473 (34.5) 91 (6.6) 64 (4.7) 1370
1997 1077 (79.5) 278 (20.5) 717 (52.9) 476 (35.1) 78 (5.8) 84 (6.2) 1355
1998 1019 (78.4) 281 (21.6) 631 (48.5) 526 (40.5) 84 (6.5) 59 (4.5) 1300
1999 1060 (77.1) 314 (22.9) 678 (49.3) 550 (40.0) 105 (7.6) 41 (3.0) 1374
2000 1051 (79.9) 264 (20.1) 592 (45.0) 573 (43.6) 92 (7.0) 58 (4.4) 1315
2001 1014 (80.5) 245 (19.5) 622 (49.4) 513 (40.7) 87 (6.9) 37 (2.9) 1259
2002 1007 (81.0) 236 (19.0) 553 (44.5) 569 (45.8) 83 (6.7) 38 (3.1) 1243
2003 961 (80.9) 227 (19.1) 559 (47.1) 510 (42.9) 68 (5.7) 51 (4.3) 1188
2004 970 (78.8) 261 (21.2) 757 (61.5) 232 (18.8) 208 (16.9) 34 (2.8) 1231
2005 998 (80.4) 243 (19.6) 740 (59.6) 254 (20.5) 206 (16.6) 41 (3.3) 1241
2006 1012 (81.4) 232 (18.6) 733 (58.9) 242 (19.5) 225 (18.1) 44 (3.5) 1244
2007 1031 (81.1) 240 (18.9) 722 (56.8) 255 (20.1) 252 (19.8) 42 (3.3) 1271
2008 990 (80.6) 238 (19.4) 708 (57.7) 245 (20.0) 227 (18.5) 48 (3.9) 1228
2009 994 (82.8) 207 (17.2) 704 (58.6) 241 (20.1) 205 (17.1) 51 (4.2) 1201
2010 1063 (81.5) 242 (18.5) 740 (56.7) 278 (21.3) 235 (18.0) 52 (4.0) 1305
2011 1002 (81.4) 229 (18.6) 677 (55.0) 263 (21.4) 242 (19.7) 49 (4.0) 1231
2012 1045 (82.0) 230 (18.0) 725 (56.9) 259 (20.3) 249 (19.5) 42 (3.3) 1275
2013 1002 (82.3) 216 (17.7) 671 (55.1) 257 (21.1) 243 (20.0) 47 (3.9) 1218
2014 997 (81.1) 233 (18.9) 682 (55.4) 257 (20.9) 234 (19.0) 57 (4.6) 1230
2015 962 (81.3) 222 (18.8) 632 (53.4) 260 (22.0) 230 (19.4) 62 (5.2) 1184
2016 984 (82.1) 215 (17.9) 634 (52.9) 296 (24.7) 217 (18.1) 52 (4.3) 1199
2017 954 (80.1) 237 (19.9) 602 (50.5) 313 (26.3) 207 (17.4) 69 (5.8) 1191
2018 889 (81.3) 204 (18.7) 568 (52.0) 283 (25.9) 178 (16.3) 64 (5.9) 1093
a

Data used to estimate incidence and mortality trends. Data are from the Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat database, released April 2021, based on the November 2020 submission. For the period from 1986 to 1991, data are from SEER 9 research data; for the period from 1992 to 2018, data are from SEER 13 research data.5